Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
+0.18%
1,084.95
+1.91
+0.18%
—1,083.041,082.631,085.331,080.59——
SIXC
Communications
SIXC
Communications
SIXC
-0.23%
601.01
-1.37
-0.23%
—602.38602.38602.38599.75——
SIXE
Energy
SIXE
Energy
SIXE
-0.04%
1,242.33
-0.50
-0.04%
—1,242.831,229.311,244.851,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.62%
1,741.53
+27.71
+1.62%
—1,713.821,715.471,742.831,715.47——
SIXM
Financials
SIXM
Financials
SIXM
-0.16%
638.98
-1.21
-0.16%
—639.99636.98639.47631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.24%
847.81
+10.35
+1.24%
—837.46840.30848.56840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.83%
215.99
+1.77
+0.83%
—214.22214.22216.14214.05——
SIXT
Technology
SIXT
Technology
SIXT
-0.77%
3,179.63
-24.75
-0.77%
—3,204.383,215.043,215.043,176.63——
SIXU
Utilities
SIXU
Utilities
SIXU
+1.83%
942.33
+16.95
+1.83%
—925.38927.91942.02927.91——
SIXV
Health care
SIXV
Health care
SIXV
+1.31%
1,461.58
+18.87
+1.31%
—1,442.711,443.011,460.661,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.12%
2,358.48
-2.86
-0.12%
—2,361.342,391.002,395.822,354.52——
LGDN:FRA
Ligand Pharmaceuticals Inc
€ 188.00
-2.08%
(-4.00) Siku 1
30 Apr, 15:44:52 GMT +2  ·   EUR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya LGDN...
Fungua
€ 190.00
Juu
€ 190.00
Chini
€ 188.00
Mtaji wa soko
4.51B
Wastani wa kiasi cha mauzo
3.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 204.00
Chini kwa wiki 52
€ 87.00
Idadi ya wafanyakazi
47
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Ligand Pharmaceuticals is an American biopharmaceutical company that focuses on acquiring and developing royalty-generating assets. As of 2024, the company's portfolio included royalty rights to approximately 90 pharmaceutical products across a range of therapeutic areas. Notable products from which Ligand receives royalties include the multiple myeloma treatments Kyprolis and Evomela, the kidney disease therapy Filspari, and the pneumococcal vaccine Vaxneuvance. The company also owns the drug development technology platform Captisol. The company was founded in 1987 as Progenx by venture capitalist Brook Byers; it was renamed Ligand Pharmaceuticals in 1989 and went public in 1992. Following an accounting scandal that led to its delisting from the Nasdaq stock exchange in 2005, the company underwent a major restructuring. Under former CEO John Higgins, who took over in 2007, Ligand shifted its focus from drug development to its current business model of generating revenue from royalties and licensing payments. Ligand has grown its portfolio primarily through acquisitions, including Pharmacopeia in 2008, CyDex Pharmaceuticals in 2011, and Pfenex in 2020. Wikipedia
Kuhusu Ligand Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi47
LilianzishwaSep 1987
Makao makuuJupiter, Florida, Marekani
Sekta-
Tovutiligand.com
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
45.33M
47.63M
115.46M
59.67M
Gharama ya bidhaa zilizouzwa
54.93M
9.47M
24.82M
6.50M
Gharama ya mapato
54.93M
9.47M
24.82M
6.50M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
18.80M
20.18M
28.45M
25.03M
Gharama ya uendeshaji
27.06M
28.43M
36.54M
33.12M
Jumla ya gharama za uendeshaji
81.99M
37.91M
61.36M
39.63M
Mapato ya uendeshaji
-36.66M
9.72M
54.10M
20.04M
Mapato mengine yasiyo ya uendeshaji
-2.06M
elfu 96.00
elfu 390.00
1.48M
EBT ikijumuisha vipengee visivyo vya kawaida
-50.18M
11.22M
141.14M
56.78M
EBT bila kujumuisha vipengee visivyo vya kawaida
-37.81M
10.28M
57.45M
116.80M
Gharama ya kodi ya mapato
-7.73M
6.38M
23.86M
12.00M
Kiwango cha kodi kinachotumika
15.40%
56.81%
16.91%
21.13%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
-42.45M
4.85M
117.27M
44.78M
Kiwango cha faida halisi
-93.64%
10.18%
101.57%
75.06%
Mapato kwa kila hisa
1.33
1.60
3.09
2.02
Mapato ya riba na uwekezaji
1.77M
1.62M
3.87M
6.39M
Gharama ya riba
elfu -867.00
-1.15M
elfu -910.00
-1.78M
Jumla ya gharama halisi za riba
elfu 904.00
elfu 468.00
2.96M
4.61M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-28.35M
17.82M
63.26M
28.25M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho